RH's Q1 revenue declined by 1.7% with margin compression despite management's upgraded guidance for fiscal year 2026. The company's recovery in the second half of the year depends on backlog normalization, new store openings, and growth in RH Estates, but execution risks remain high. Margin pressures continue due to rising occupancy costs, international expansion expenses, and declining product margins in the core business. Trading at about 25 times next twelve months price-to-earnings ratio and a premium to peers, RH needs clear evidence of growth and margin recovery in H2 to justify further upside.
Sagimet Biosciences announced its management will participate in the Leerink Partners Therapeutics Forum on July 15, 2026, to engage with investors. The company also granted 34,300 stock options to two newly hired employees as an inducement under Nas...
In 2025, AI-related companies raised at least $200 billion in debt to finance data center buildouts, marking one of the largest tech sector financing efforts ever. Financial expert Jim Rickards highlights that much of this debt is held through comple...
Celtic Lux Holdings, formerly Alvogen Lux Holdings, purchased 10,133,333 shares of Alvotech at $3.75 per share on June 16, 2026. This transaction was reported to the Luxembourg financial regulator, CSSF, indicating significant insider activity. The p...
FTI Consulting appointed Jerome Nyssen as Senior Managing Director in its Risk Advisory practice in Australia to enhance AI-driven risk, compliance, and governance services. Nyssen brings 25 years of experience across financial services and technolog...
Dogecoin (DOGE) is approaching a crucial price zone near $0.10, a psychological level called the "zero removal rally." Currently trading around $0.084, DOGE has faced selling pressure after breaking below a support trendline but has held above $0.08,...
